Evidence map›Paper›PMID 25775607›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation.

Jonggul Kim, Larry R Masterson, Alessandro Cembran, Raffaello Verardi, Lei Shi, Jiali Gao, Susan S Taylor, Gianluigi Veglia

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Phospholamban cardiomyopathy: a Canadian perspective on a unique population.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Binding mechanism and dynamic conformational change of C subunit of PKA with different pathways.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Altering the allosteric pathway in IGPS suppresses millisecond motions and catalytic activity.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).The Journal of biological chemistry · 2015
    Article
  20. Dynamics-Driven Allostery in Protein Kinases.Trends in biochemical sciences · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jonggul KimDepartments of Chemistry and.
Larry R MastersonBiochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455;
Alessandro CembranDepartments of Chemistry and Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455;
Raffaello VerardiBiochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455;
Lei ShiDepartments of Chemistry and.
Jiali GaoDepartments of Chemistry and Theoretical Chemistry Institute, Jilin University, Changchun 130028, People's Republic of China; and.
Susan S TaylorHoward Hughes Medical Institute and Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093 staylor@ucsd.edu vegli001@umn.edu.
Gianluigi VegliaDepartments of Chemistry and Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455; staylor@ucsd.edu vegli001@umn.edu.
University of Minnesota · USHoward Hughes Medical Institute · USJilin University · CN

Funding

TRAINING PROGRAM IN MUSCLE RESEARCHT32AR007612 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JAMES M ERVASTI, DAWN A LOWE · 2001 to 2026
$11.3M
BIOMOLECULAR INTERACTIONS AND ENZYMATIC PROCESSESR01GM046736 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JIALI GAO · 1993 to 2026
$6.5M
Structural Basis Of Dilated CardiomyopathyR01GM072701 · NIGMS · UNIVERSITY OF MINNESOTA · PI VEGLIA, GIANLUIGI · 2007 to 2015
$2.4M
T-CELL RECOGNITION USING SOLUBLE RECEPTORSR01GM046367 · NIGMS · YALE UNIVERSITY · PI BOTHWELL, ALFRED LM · 1993 to 1999
–
Howard Hughes Medical InstituteNIAMS NIH HHS T32 AR007612NIGMS NIH HHS GM46367NIGMS NIH HHS GM72701NIGMS NIH HHS R01 GM046736NIGMS NIH HHS R01 GM072701
6 · The paper itself

Abstract

The dynamic interplay between kinases and substrates is crucial for the formation of catalytically committed complexes that enable phosphoryl transfer. However, a clear understanding on how substrates modulate kinase structural dynamics to control catalytic efficiency is still missing. Here, we used solution NMR spectroscopy to study the conformational dynamics of two complexes of the catalytic subunit of the cAMP-dependent protein kinase A with WT and R14 deletion phospholamban, a lethal human mutant linked to familial dilated cardiomyopathy. Phospholamban is a central regulator of heart muscle contractility, and its phosphorylation by protein kinase A constitutes a primary response to β-adrenergic stimulation. We found that the single deletion of arginine in phospholamban's recognition sequence for the kinase reduces its binding affinity and dramatically reduces phosphorylation kinetics. Structurally, the mutant prevents the enzyme from adopting conformations and motions committed for catalysis, with concomitant reduction in catalytic efficiency. Overall, these results underscore the importance of a well-tuned structural and dynamic interplay between the kinase and its substrates to achieve physiological phosphorylation levels for proper Ca(2+) signaling and normal cardiac function.

Indexed as

MutationAllosteric SiteAmino Acid SequenceCalciumCalcium-Binding ProteinsCalcium-Transporting ATPasesCardiomyopathy, DilatedCatalytic DomainCyclic AMP-Dependent Protein KinasesDisease ProgressionGene DeletionHumansLigandsMagnetic Resonance SpectroscopyMolecular Dynamics SimulationMolecular Sequence DataCalciumCalcium-Binding ProteinsCalcium-Transporting ATPasesCyclic AMP-Dependent Protein KinasesLigandsPhospholambancalcium regulationconformational dynamicsNMRphospholambanphosphorylation

Identifiers

PMID25775607
PMCPMC4378435
OpenAlexW2127992862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.